02/14/2025
4:08 PM | Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
4:43 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
02/10/2025
6:57 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
02/10/2025
6:54 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/05/2025
5:45 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
01/31/2025
6:47 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2025
6:51 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
01/30/2025
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/28/2025
9:46 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
01/28/2025
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2025
4:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
Get the Latest News and Ratings for NLSP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NLS Pharmaceutics and its competitors with MarketBeat's FREE daily newsletter. |
01/16/2025
8:20 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2025
8:22 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
01/14/2025
3:27 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2025
7:04 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2025
7:14 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
01/07/2025
3:30 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024
7:52 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024
7:54 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
12/30/2024
5:13 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions | |
12/23/2024
3:04 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024
3:23 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K/A | |
12/19/2024
7:30 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024
7:32 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
12/17/2024
3:30 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024
7:30 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024
7:32 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
12/10/2024
7:30 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K/A | |
12/03/2024
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/26/2024
11:15 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form EFFECT | |
11/21/2024
3:01 PM | Hafner Ronald (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G/A | |
11/18/2024
7:30 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2024
4:00 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
6:27 PM | Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G/A | |
11/08/2024
3:00 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2024
3:30 PM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
11/05/2024
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
6:39 PM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
YA II PN, Ltd. (Filed by)
| Form SC 13G/A | |
11/04/2024
5:20 PM | Grisard Felix (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G/A | |
11/04/2024
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
7:02 AM | NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
The Real Hillbilly Elegy (Ad) The mountains of Appalachia are incredible to behold.
Spanning thousands of miles across Alabama, Kentucky, Tennessee and beyond…
It's one of our country’s most scenic areas. But hidden beneath the beauty is an ugly reality: our most beautiful land is also the poorest.
It’s a tragedy because for over 200 years, generation after generation has worked “coal country” with nothing but a pick and shovel, hauling billions of dollars from the ground. A bold new plan, hidden in Executive Order 14154… |
10/28/2024
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/23/2024
3:00 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
10/22/2024
3:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024
4:19 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/18/2024
3:31 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024
12:24 PM | ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G | |
10/15/2024
8:09 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
7:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
6:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/01/2024
3:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024
7:13 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2024
3:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024
4:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024
3:01 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
08/26/2024
3:40 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024
3:30 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
8:16 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/01/2024
7:26 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 424B5 | |
07/01/2024
7:09 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024
3:54 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
11:15 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form EFFECT | |
06/25/2024
3:31 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
8:28 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
8:13 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
4:25 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024
8:10 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
4:16 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
3:11 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024
6:37 PM | Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G | |
03/22/2024
9:24 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 424B5 | |
03/21/2024
4:14 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
11:58 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
8:06 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
8:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
